Literature DB >> 11566723

Expression and localization of the contractile prostaglandin F receptor in pregnant rat myometrium in late gestation, labor, and postpartum.

H Y Al-Matubsi1, A L Eis, J Brodt-Eppley, D J MacPhee, S Lye, L Myatt.   

Abstract

A polyclonal antibody was raised against amino acids 7-18 in the first extracellular loop of rat prostaglandin F (FP) receptor to monitor expression and localization in pregnant rat myometrium at Gestational Days 16, 18, 20, 21, 21.5, 22 (delivery), and 23 (1-day postpartum; n = 5 per group). The antibody recognized a protein of approximately 43 kDa on Western blot analysis in both membrane (soluble and nonsoluble) and cytosolic fractions of myometrium on each day of gestation. Expression of FP protein increased significantly (P < 0.05) during late gestation in both soluble membrane and cytosolic fractions, being significantly greater at Day 21.5 than at Day 20 of gestation in the soluble membrane fraction and in the cytosolic fraction of tissues collected during labor compared with those obtained before labor. The total concentration of FP receptor in the membrane (soluble plus nonsoluble) remained high throughout late gestation and fell significantly (P < 0.05) in the postpartum period. The FP receptor in the soluble membrane fraction (compared to the total membrane FP receptor) was significantly (P < 0.05) higher in late gestation than earlier, whereas the ratio of FP protein in cytosolic to that in the total membrane was significantly (P < 0.05) higher on Day 23 than earlier in gestation, suggesting a dynamic movement of FP with advancing gestational age. Immunoreactive FP receptor localized to circular and longitudinal smooth muscle at all gestational ages, but changes in intracellular localization were observed in late gestation with a staining pattern similar to alpha-actin, suggesting an association with myofibrils. Our study suggests an increase in FP-receptor protein in myometrium with advancing gestation and a marked elevation at term. This supports a role for uterine FP receptors in mediation of uterine contractility at term.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11566723     DOI: 10.1095/biolreprod65.4.1029

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  6 in total

1.  Pharmacokinetics, safety and tolerability of OBE022, a selective prostaglandin F2α receptor antagonist tocolytic: A first-in-human trial in healthy postmenopausal women.

Authors:  Oliver Pohl; Line Marchand; Jean-Pierre Gotteland; Simon Coates; Jörg Täubel; Ulrike Lorch
Journal:  Br J Clin Pharmacol       Date:  2018-06-05       Impact factor: 4.335

2.  A decline in the levels of progesterone receptor coactivators in the pregnant uterus at term may antagonize progesterone receptor function and contribute to the initiation of parturition.

Authors:  Jennifer C Condon; Pancharatnam Jeyasuria; Julie M Faust; James W Wilson; Carole R Mendelson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-28       Impact factor: 11.205

3.  Relationship between gene expression and function of uterotonic systems in the rat during gestation, uterine activation and both term and preterm labour.

Authors:  Patrice Arthur; Michael J Taggart; Barbara Zielnik; Susan Wong; Bryan F Mitchell
Journal:  J Physiol       Date:  2008-10-20       Impact factor: 5.182

4.  Tocolytic effect of a selective FP receptor antagonist in rodent models reveals an innovative approach to the treatment of preterm labor.

Authors:  André Chollet; Enrico Gillio Tos; Rocco Cirillo
Journal:  BMC Pregnancy Childbirth       Date:  2007-06-01       Impact factor: 3.007

5.  Prostaglandin F2-alpha receptor (FPr) expression on porcine corpus luteum microvascular endothelial cells (pCL-MVECs).

Authors:  Augusta Zannoni; Chiara Bernardini; Tommaso Rada; Luciana A Ribeiro; Monica Forni; Maria L Bacci
Journal:  Reprod Biol Endocrinol       Date:  2007-07-20       Impact factor: 5.211

6.  Prostaglandin F receptor expression in intrauterine tissues of pregnant rats.

Authors:  Elvan Anadol; Halit Kanca; Atiye Seda Yar; Fatma Helvacioğlu; Sevda Menevşe; Engin Calgüner; Deniz Erdoğan
Journal:  J Vet Sci       Date:  2013-10-18       Impact factor: 1.672

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.